“WHO’s global hepatitis strategy aims to reduce new hepatitis infections by 90% and deaths by 65% between 2016 and 2030.
STIs is very common all over the world. More than 1 million cases of curable STIs new infected happens each day.
With surging cases of prevailing SARS-CoV-2 Delta variant, the testing of the variant has become a necessary and important measure to curb the further spread of the virus.
Bioperfectus is pleased to launch Research Only Only (RUO) products to the global market
We Bioperfectus would like to take this special moment to wish all of our Muslim communities a Happy Eid Al-Adha 2021.
With the ongoing COVID-19 variants rise across the globe, Bioperfectus sets out for testing in the post-pandemic era.
BfArM grants Bioperfectus special approval for COVID-19 antigen self-test
Today, Bioperfectus is thrilled to launch the unprecedented nucleic acid extraction system SMPE-960
Catch the last chance to register for upcoming Bioperfectus 2nd Global Distributors Conference
Copyright © 2010-2021 Jiangsu Bioperfectus Technologies Co., Ltd All Rights Reserved.
Tel: +86 021-5484 7326